在孕妇患有慢性高血压的孕妇中优化分娩时间
Ira Hamilton1, James Liu1, Labeena Wajahat1
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
O&G open
|September 26, 2025
概括
对于患有慢性高血压的孕妇,怀孕39周的分娩通过平衡婴儿死亡,新生儿发病率和死产风险来优化结果. 这一时间与改善母婴健康的当前临床指导方针相一致.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 周围生理学 周围生理学
背景情况:
- 慢性高血压是怀孕的一个常见并发症.
- 在这些怀孕中,最佳的分娩时间对于尽量减少不良结果至关重要.
- 现有的指导方针建议个性化评估,但具体的妊娠年龄目标仍在讨论中.
研究的目的:
- 为了确定最佳的怀孕周,以分娩在由慢性高血压复杂的终期怀孕.
- 为了比较分娩风险与每周怀孕的预期管理,从37周到42周.
主要方法:
- 基于人口的美国出生 (2014-2018) 的回顾性队列研究.
- 包括慢性高血压患者的非异常单期分娩 (不包括叠加的孕前,孕后和糖尿病).
- 死亡出生,婴儿死亡和综合新生儿病率 (NICU入院,通风,低Apgar,发作) 的比较率与期望管理的风险每周.
主要成果:
- 死产率随着妊娠年龄的增加而增加,在38周时最低.
- 婴儿死亡率在40周是最低的,新生儿发病率在39周是最低的.
- 在39周的分娩显示,与其他周相比,复合风险较低 (分娩与预期管理).
结论:
- 怀孕39周的分娩提供了婴儿死亡,新生儿发病率和长期高血压妊娠中死产风险的最佳平衡.
- 这一发现适用于包括非西班牙裔黑人患者和胎儿生长限制患者的子组分析.
- 这些结果支持当前的临床实践指南,建议在39周左右分娩.
相关概念视频
Hypertension V: Nursing Management
359
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
359
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
353
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
353
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212


